CSIR-IICT, NIIST, Suven Pharma sign MoU for Molnupiravir
The anti-viral drug was initially developed for the treatment of influenza and has been repurposed to treat COVID-19
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.